<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 4; Issue 6</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Nov-Dec, 2023)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>How to Provide Tailored Medication Counselling to Hematology Patients? A Pilot Project</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>4</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Damien S.E.</FirstName>
          <LastName>Broekharst</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Diana</FirstName>
          <LastName>Bervoets</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Lamyae</FirstName>
          <LastName>Maanach</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Sjaak</FirstName>
          <LastName>Bloem</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Hematological diseases are characterized by ample variance in disease trajectories requiring the delivery of tailored medication counselling. However, the one size fits all approach to providing medication counselling still seems pervasive in hospitals. Therefore, the outpatient pharmacy of the Albert Schweitzer hospital in the Netherlands implemented a pilot project concerning tailored allocation of medication counselling among hematology patients through structural assessment of their needs. The 124 included hematology patients were provided with tailored medication counselling by trained pharmacy assistants for 12 months. The tailored medication counselling provided to the hematology patients was based on the assessments of their needs using the Bloem __ampersandsign Stalpers segmentation model. This model constitutes four segments each describing a medication counselling profile based on the perceived acceptance and control of patients. The evaluation of this pilot project shows that subjective health experience, satisfaction with medication information and medication compliance among included patients improved.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Medication Counselling,Hematology,Hematology Patients,Subjective Health Experience,Satisfaction with Medication Information,Medication Compliance</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=14984&amp;title=How to Provide Tailored Medication Counselling to Hematology Patients? A Pilot Project</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Bloem S, Stalpers J, Groenland EAG, van Montfort K, van Raaij WF, de Rooij K. Segmentation of health-care consumers: psychological determinants of subjective health and other person-related variables. BMC Health Serv Res 2020; 20: 726.&#13;
&#13;
Broekharst DSE, Bloem S, Groenland EAG, van Raaij WF, van Agthoven M. Differences between expert reported and patient reported burden of disease rankings. Sci Rep 2022; 12: 895.&#13;
&#13;
Chan AHY, Horne R, Hankins M, Chisari C. The Medication Adherence Report Scale: A measurement tool for eliciting patientsand;#39; reports of nonadherence. Br J Clin Pharmacol 2020; 86: 1281-1288.&#13;
&#13;
Efficace F, Gaidano G, Lo-Coco F. Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood 2017; 130: 859–866.&#13;
&#13;
Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001; 10: 135-140.&#13;
&#13;
Keykhaei M, Masinaei M, Mohammadi E, Azadnajafabad S, Rezaei N, Saeedi Moghaddam S, Rezaei N, Nasserinejad M, Abbasi-Kangevari M, Malekpour MR, Ghamari SH, Haghshenas R, Koliji K, Kompani F, Farzadfar F. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990-2017. Exp Hematol Oncol 2021; 10: 11.&#13;
&#13;
Shah GL, Majhail N, Khera N, Giralt S. Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities. Curr Hematol Malig Rep 2018; 13: 125-134.&#13;
&#13;
Showande SJ, Laniyan MW. Patient medication counselling in community pharmacy: evaluation of the quality and content. J Pharm Policy Pract 2022; 15: 103.&#13;
&#13;
Tzelepis F, Clinton-McHarg T, Paul CL, Sanson-Fisher RW, Joshua D, Carey ML. Quality of Patient-Centered Care Provided to Patients Attending Hematological Cancer Treatment Centers. Int J Environ Res Public Health 2018 Mar 19;15(3):549.&#13;
&#13;
Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, Ma L, Liu X, Zhou F. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 2023; 13: 82.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>